McDonald's Hit By Data Breach In Taiwan, South Korea, US

McDonald's (MCD) becomes the latest company to be hit by a data breach after its stores in a various countries including Taiwan, South Korea, and the United States were hacked.

The issue was discovered when unauthorized activity on an internal security system was noticed. The fast-food chain said it was able to quickly identify the breach and contain it.

"While we were able to close off access quickly after identification, our investigation has determined that a small number of files were accessed, some of which contained personal data," the company said.

According to reports, no customer data was breached in the U.S., but in Taiwan and South Korea some customer emails, phone numbers, and addresses for delivery customers were stolen. However, no customer payment information was exposed.

Hackers have been targeting businesses across various industry in the past couple of months. JBS, the world's largest meat processing company, revealed that it paid nearly $11 million in bitcoins to hackers who hacked its computer system last month. Colonial Pipeline also paid a ransom of 75 bitcoin, which is nearly $4.4 million, after hackers blocked its pipeline system.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Flavor maker McCormick & Co., Inc. is recalling certain McCormick and Frank's brand seasoning products citing possible salmonella risk, the U.S. Food and Drug Administration said. The recall involves McCormick Perfect Pinch Italian Seasoning, McCormick Culinary Italian Seasoning and Frank's RedHot Buffalo Ranch Seasoning. Drug major Pfizer Inc. raised Wednesday its outlook for fiscal 2021 earnings and revenues following strong second quarter results that exceeded market estimates. According to the company, the upward revision in full-year outlook, for the second quarter in a row, reflects its updated expectations for contributions to 2021 performance from both BNT162b2, the Pfizer-BioNTech SE COVID-19 vaccine. While reporting financial results for the second quarter on Wednesday, biopharmaceutical company Bristol-Myers Squibb Co. (BMY) reaffirmed its adjusted earnings and revenue growth guidance for the full-year 2021. For fiscal 2021, the company now projects earnings in a range of $3.18 to $3.38 per share,...
Follow RTT